Page last updated: 2024-08-25

rosiglitazone and glycosides

rosiglitazone has been researched along with glycosides in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cawthorne, MA; Coyle, PJ; Holder, JC; Holman, GD; Kirkham, DM; Kozka, IJ; Lister, CA; Smith, SA; Young, PW	1
Angulo, D; Atiee, G; Corr, C; Hyman, M; Murphy, G; Willett, M; Wring, S	1

Trials

1 trial(s) available for rosiglitazone and glycosides

Article	Year
Lack of Impact by SCY-078, a First-in-Class Oral Fungicidal Glucan Synthase Inhibitor, on the Pharmacokinetics of Rosiglitazone, a Substrate for CYP450 2C8, Supports the Low Risk for Clinically Relevant Metabolic Drug-Drug Interactions. Journal of clinical pharmacology, 2018, Volume: 58, Issue:10 Topics: Adult; Antifungal Agents; Area Under Curve; Cytochrome P-450 CYP2C8; Drug Administration Schedule; Drug Interactions; Female; Glucosyltransferases; Glycosides; Half-Life; Humans; Male; Rosiglitazone; Triterpenes	2018

Article

Year

Lack of Impact by SCY-078, a First-in-Class Oral Fungicidal Glucan Synthase Inhibitor, on the Pharmacokinetics of Rosiglitazone, a Substrate for CYP450 2C8, Supports the Low Risk for Clinically Relevant Metabolic Drug-Drug Interactions.

Journal of clinical pharmacology, 2018, Volume: 58, Issue:10

Topics: Adult; Antifungal Agents; Area Under Curve; Cytochrome P-450 CYP2C8; Drug Administration Schedule; Drug Interactions; Female; Glucosyltransferases; Glycosides; Half-Life; Humans; Male; Rosiglitazone; Triterpenes

2018

Other Studies

1 other study(ies) available for rosiglitazone and glycosides

Article	Year
Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Diabetes, 1995, Volume: 44, Issue:9 Topics: Adipocytes; Adipose Tissue; Affinity Labels; Animals; Azides; Blood Glucose; Cell Membrane; Cholesterol; Diabetes Mellitus, Type 2; Diet; Disaccharides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Epididymis; Fatty Acids, Nonesterified; Glucose; Glucose Tolerance Test; Glucose Transporter Type 4; Glycosides; Hypoglycemic Agents; Insulin; Kinetics; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Monosaccharide Transport Proteins; Muscle Proteins; Propylamines; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides	1995

Article

Year

Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.

Diabetes, 1995, Volume: 44, Issue:9

Topics: Adipocytes; Adipose Tissue; Affinity Labels; Animals; Azides; Blood Glucose; Cell Membrane; Cholesterol; Diabetes Mellitus, Type 2; Diet; Disaccharides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Epididymis; Fatty Acids, Nonesterified; Glucose; Glucose Tolerance Test; Glucose Transporter Type 4; Glycosides; Hypoglycemic Agents; Insulin; Kinetics; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Monosaccharide Transport Proteins; Muscle Proteins; Propylamines; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides

1995